ABSK141

ABSK141 · Abbisko Therapeutics Co, Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABSK141, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) [Phase 1, Phase 2]